Efficacy, adherence and persistence of various glucagon‐like peptide‐1 agonists: nationwide real‐life data

Abstract

Weekly GLP-1RAs initiators were more adherent, persistent to therapy and achieved better glycaemic control. Epidemiological variables might play a role in achieving this goal.